Macrophage-MSC interactions are dynamic. Following injury, neutral (M0) macrophages arrive at the defect site and polarize towards M1 (pro-inflammatory) macrophages, which can secrete inflammatory an....

Erik R. Nelson, ENDO 2026 Annual Committee Basic Science Chair, shares program highlights for from sessions featuring prominent researchers to networking opportunities. Join us in Chicago, IL, US, June 13–16, for the latest research and connections fro...

Gisella Carranza Leon, MD, ENDO 2026 Annual Meeting Chair, shares program highlights and what she’s most excited for at ENDO 2026, taking place June 13–16: https://bit.ly/3RkyDUx She covers how we have sessions for everyone, no matter their study or ca...

Cholesterol efflux protein ABCA1 shifts macrophages to being anticancer, highlighting its potential use as a therapeutic target.

We are excited to announce the ENDO 2026 Plenaries! Taking place June 13-16, 2026, in Chicago, IL, USA, ENDO will bring together world-renowned speakers to showcase the latest developments in hormone science and medicine. Hear our president, Carol Lange, PhD, announce the distinguished plenary speakers and what they will be exploring at ENDO 2026. Learn more: https://bit.ly/4pknKyl Plenary sessions include: • Unraveling Hormonal Complexity: Genomics, Sex Differences, and Physiology • Metabolism in Motion: Endocrine Regulation as a Launchpad for Therapeutic Innovation • Molecular Mechanisms in Hormone Signaling: From Bench to Bedside

ENDO 2026 Call for Abstracts

Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, discusses how submitting a session idea can help you in your career. She also provides insight on how the AMSC uses session ideas to create ENDO programming. Submit your session suggestions and symposia proposals by Tuesday, September 2: https://bit.ly/4flCMjl #ENDO2026

YouTube video by Peter Weatherall

University of Illinois researchers have successfully treated a common type of colorectal cancer tumor with a cholesterol inhibitor drug, demonstrating a promising treatment for the disease in animal experiments.

YouTube video by Duke University

CHAMPAIGN, Ill. (WAND)- Erik Nelson is a professor of Molecular and Integrative Physiology at the University of Illinois. Nelson is also the program leader of the Cancer Center of Illinois

I receive the Daily Illini‘s newsletter that goes out every so often, showcasing the stories by University of Illinois students working on their craft and publishing stories that they’ve been working ...